Biogen’s CEO may have been celebrating “turning a corner” last month, but it looks like the drugmaker’s early-stage pipeline hasn’t gotten the message yet. The Cambridge, Massachusetts ...

In a Canadian discovery powered by philanthropy, a team of Western University researchers led by Dr. Michael Strong has uncovered a potential path toward a cure for amyotrophic lateral sclerosis ...

Fueled by a $10-million donation from the Temerty Foundation, a possible new amyotrophic lateral sclerosis (ALS) treatment could move to clinical trials in three to five years. Researchers at ...

MOUNT PLEASANT — Rory Hart, 22, hoped that his sudden weakness, fatigue and odd reflex responses were just his own immune system attacking the nerves in his body. He hoped it was Guillain-Barre ...

CLEVELAND, Ohio — ALS or Amyotrophic Lateral Sclerosis, better known to many as Lou Gehrig's Disease, is a degenerative nervous system disease that weakens muscles and impacts total body function.

PrimeC, a treatment candidate for amyotrophic lateral sclerosis (ALS), was found to significantly slow disease progression in certain subgroups of patients in the ongoing PARADIGM Phase 2b trial, ...